Modern Aspects of Immunotherapy with Checkpoint Inhibitors in Melanoma

Although melanoma is one of the most immunogenic tumors, it has an ability to evade anti-tumor immune responses by exploiting tolerance mechanisms, including negative immune checkpoint molecules. The most extensively studied checkpoints represent cytotoxic T lymphocyte-associated protein-4 (CTLA-4)...

Descripción completa

Detalles Bibliográficos
Autores principales: Petrova, Vera, Arkhypov, Ihor, Weber, Rebekka, Groth, Christopher, Altevogt, Peter, Utikal, Jochen, Umansky, Viktor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7178114/
https://www.ncbi.nlm.nih.gov/pubmed/32235439
http://dx.doi.org/10.3390/ijms21072367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7178114/
https://www.ncbi.nlm.nih.gov/pubmed/32235439
http://dx.doi.org/10.3390/ijms21072367

Ejemplares similares